Protein Expression Market to Reach $6.21 Billion by 2035
Protein expression market was valued at $3.05 billion in 2025 and is projected to reach $6.21 billion by 2035, growing at a CAGR of 7.37% during the forecast period (2026–2035). The rising demand for biologics and recombinant proteins is significantly driving the adoption of advanced protein expression technologies across pharmaceutical and biotechnology industries. Protein expression systems are essential for producing therapeutic proteins, enzymes, and vaccines at scale, making them a critical component of modern drug development and life sciences research. The increasing burden of chronic diseases and the shift toward biologics-based therapies are accelerating market growth.
Browse the full report description of “Protein Expression Market Size, Share & Trends Analysis Report, By Expression System (Prokaryotic Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Mammalian Cell Expression Systems, Cell-Free Expression Systems), By Product Type (Expression Vectors & Plasmids, Competent Cells, Expression Kits & Reagents, Instruments), By Application (Therapeutic Protein Production, Vaccine Development, Industrial Enzyme Production, Research & Academic Applications), By Workflow Stage (Gene Cloning & Vector Construction, Protein Expression, Protein Purification), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/protein-expression-market
According to the World Health Organization, chronic diseases account for over 70% of global deaths annually, driving demand for advanced biologic treatments such as monoclonal antibodies and recombinant proteins. Additionally, data from International Federation of Pharmaceutical Manufacturers & Associations highlights that more than half of the global pharmaceutical pipeline consists of biologics, reinforcing the need for efficient protein production platforms. These trends are directly supporting the adoption of mammalian and cell-free expression systems to achieve higher protein yield and scalability.
Biopharmaceutical Expansion and Vaccine Production Demand
The expansion of vaccine manufacturing and biologics production is further strengthening the market. The WHO reports that global immunization programs deliver vaccines to over 4 billion people annually, requiring large-scale protein expression for antigen production. The continued investment in vaccine R&D and production infrastructure is increasing demand for expression systems, reagents, and purification technologies. Furthermore, regulatory approvals for recombinant biologics are increasing, with the U.S. Food and Drug Administration approving a growing number of biologics each year, reinforcing the importance of protein expression technologies in therapeutic development.
Key Leaders Transforming the Protein Expression Market
The key players in the protein expression market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, and Cytiva, among others. These companies are focusing on innovation in expression systems, automation, and high-throughput protein production technologies.
- In November 2025, LenioBio announced a strategic collaboration with the AI-guided antibody design firm mAIbe. The partnership combines mAIbe's physics-informed generative AI platform for de novo antibody optimization with LenioBio's scalable cell-free eukaryotic protein expression platform. This closed-loop setup aims to drastically shorten the traditional "design-build-test" cycles for complex monoclonal antibodies.
- In April 2025, Thermo Fisher introduced an enhanced platform featuring a new CHO K-1 cell line designed to slash the timeline to Investigational New Drug (IND) filing from 13 down to 9 months. The new line produces higher expression titers of up to 8g/L, vastly increasing protein expression yield and stability for biopharma clients moving from pre-clinical phases to commercial supply.
Technological advancements such as synthetic biology, automation, and cell-free expression systems are further improving efficiency and reducing production timelines. These innovations are enabling faster drug discovery, scalable manufacturing, and improved protein quality, making protein expression technologies indispensable across pharmaceutical, industrial, and academic sectors.
Market Coverage
- The market number available for – 2025-2035
- Base year- 2025
- Forecast period- 2026-2035
- Segment Covered-
- Expression System
- Product Type
- Application
- Workflow Stage
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape – Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, Cytiva, among others.
Key questions addressed by the report.
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Protein Expression Market Report Segment
By Expression System
- Prokaryotic Expression Systems
• Yeast Expression Systems
• Insect Cell Expression Systems
• Mammalian Cell Expression Systems
• Cell-Free Expression Systems
By Product Type
- Expression Vectors & Plasmids
• Competent Cells
• Expression Kits & Reagents
• Instruments
By Application
- Therapeutic Protein Production
• Vaccine Development
• Industrial Enzyme Production
• Research & Academic Applications
By Workflow Stage
- Gene Cloning & Vector Construction
• Protein Expression
• Protein Purification
Global Protein Expression Market Report Segment by Region
North America
- United States
• Canada
Europe
- UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
Asia-Pacific
- China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific
Rest of the World
- Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/protein-expression-market